Register for the CYP1B1 test

Estrogen exposure is a know risk factor for breast and prostate cancer. Enzymes associated with detoxification help control the conversion of estrogen into potentially carcinogenic metabolites. CYP1B1 gene single nucleotide polymorphisms (SNPs) resulting in protein alterations have been suggested to impact the conversion of estrogen to carcinogenic metabolites. If you have a SNP on CYP1B1, you are more likely to produce these carcinogenic metabolites. Specific nutritional supplements can counteract this effect and can lower your risk for either breast or prostate cancer.